Healthcare provider profile · identity verified

Daniel W Rodriguez, MD

Internal Medicine · NORTH CANTON, OH · NPI 1447228457

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	576	137
Amlodipine Besylate	Amlodipine Besylate	517	124
Rosuvastatin Calcium	Rosuvastatin Calcium	431	115
Levothyroxine Sodium	Levothyroxine Sodium	380	79
Losartan Potassium	Losartan Potassium	324	80
Lisinopril	Lisinopril	247	59
Pantoprazole Sodium	Pantoprazole Sodium	220	55
Allopurinol	Allopurinol	198	39
Omeprazole	Omeprazole	188	54
Metoprolol Succinate	Metoprolol Succinate	187	47
Potassium Chloride	Potassium Chloride	182	41
Sertraline Hcl	Sertraline Hcl	178	38
Eliquis	Apixaban	177	30
Simvastatin	Simvastatin	174	49
Metformin Hcl	Metformin Hcl	172	40
Alprazolam	Alprazolam	167	33
Chlorthalidone	Chlorthalidone	166	34
Fluticasone Propionate	Fluticasone Propionate	158	48
Olmesartan Medoxomil	Olmesartan Medoxomil	154	43
Escitalopram Oxalate	Escitalopram Oxalate	150	35
Furosemide	Furosemide	142	32
Tamsulosin Hcl	Tamsulosin Hcl	127	27
Lorazepam	Lorazepam	125	23
Valsartan	Valsartan	124	23
Carvedilol	Carvedilol	123	35
Metoprolol Tartrate	Metoprolol Tartrate	123	23
Duloxetine Hcl	Duloxetine Hcl	120	28
Metformin Hcl Er	Metformin Hcl	119	30
Trazodone Hcl	Trazodone Hcl	108	21
Glipizide Er	Glipizide	106	27
Pravastatin Sodium	Pravastatin Sodium	93	24
Gabapentin	Gabapentin	91	15
Bupropion Xl	Bupropion Hcl	81	18
Synthroid	Levothyroxine Sodium	72	15
Prednisone	Prednisone	71	37
Esomeprazole Magnesium	Esomeprazole Magnesium	66	17
Jardiance	Empagliflozin	66	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	66	11
Albuterol Sulfate Hfa	Albuterol Sulfate	63	29
Clopidogrel	Clopidogrel Bisulfate	57	13
Lansoprazole	Lansoprazole	53	13
Celecoxib	Celecoxib	51	suppressed
Meloxicam	Meloxicam	51	19
Citalopram Hbr	Citalopram Hydrobromide	50	11
Mirtazapine	Mirtazapine	49	suppressed
Glipizide	Glipizide	47	suppressed
Ozempic	Semaglutide	47	suppressed
Clonazepam	Clonazepam	46	suppressed
Atenolol	Atenolol	44	12
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Spironolactone	Spironolactone	37	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	36	11
Donepezil Hcl	Donepezil Hcl	35	suppressed
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	27
Famotidine	Famotidine	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Methylprednisolone	Methylprednisolone	27	25
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Bumetanide	Bumetanide	25	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	16
Ramipril	Ramipril	23	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	23	suppressed
Febuxostat	Febuxostat	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Azithromycin	Azithromycin	20	17
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Amoxicillin	Amoxicillin	19	16
Nitroglycerin	Nitroglycerin	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Benazepril Hcl	Benazepril Hcl	18	suppressed
Finasteride	Finasteride	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Cephalexin	Cephalexin	16	16
Ondansetron Hcl	Ondansetron Hcl	16	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Dofetilide	Dofetilide	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Moexipril Hcl	Moexipril Hcl	13	suppressed
Verapamil Hcl	Verapamil Hcl	13	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Nystatin	Nystatin	12	suppressed
Topiramate	Topiramate	12	suppressed
Verapamil Er Pm	Verapamil Hcl	12	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	11	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Nadolol	Nadolol	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Temazepam	Temazepam	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error